Evolus logo

Press Releases

Press Releases
Sep 08, 2020
NEWPORT BEACH, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in three upcoming virtual investor
Jul 06, 2020
Pro Forma Cash¹ Position of $125 Million at June 30, 2020 NEWPORT BEACH, Calif. , July 06, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced that its strategic partner, Daewoong Pharmaceutical Co. Ltd., will invest $40 million in a five-year, unsecured, subordinated, 3%
May 11, 2020
NEWPORT BEACH, Calif. , May 11, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today reported financial results for the first quarter ended March 31, 2020 and provided a business
Apr 16, 2020
NEWPORT BEACH, Calif. , April 16, 2020 (GLOBE NEWSWIRE) -- Evolus , Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced a pre-emptive plan to support the U.S. aesthetic neurotoxin market in light of the
Mar 04, 2020
Company Remains Confident in its Intellectual Property and the Overall Merits of the Case NEWPORT BEACH, Calif. , March 04, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today provided the following statement: “In several media reports this week, Medytox has made comments on the
Mar 03, 2020
NEWPORT BEACH, Calif. , March 03, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that management will be participating in the Barclays 2020 Global Healthcare Conference
Displaying 1 - 10 of 15